Here are five insights:
1. Under the agreement, Xtant gains a presence in the lateral lumbar interbody fusion market.
2. The distribution agreement expands the system’s availability.
3. The InFill Lateral Fusion System allows surgeons to deliver bone graft material to the fusion device in situ.
4. The system is designed for use in the lumbar spine, from L2 to S1.
5. The U.S. lateral lumbar interbody fusion market is anticipated to reach $309 million in 2020, according to iData Research.
More articles on devices:
Dr. Ramon Cugat to present Cytori Cell Therapy for ACL reconstruction study results — 5 things to know
Medtronic expects surgical robot to generate ‘meaningful’ revenue in 2019: 7 key points on the device company’s next steps
How effective are electrical bone stimulators for bone healing? Dr. Mohit Bhandari weighs in with new evidence
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
